This is a Validated Antibody Database (VAD) review about dog CBL, based on 5 published articles (read how Labome selects the articles), using CBL antibody in all methods. It is aimed to help Labome visitors find the most suited CBL antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CBL synonym: E3 ubiquitin-protein ligase CBL; LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase CBL; Cas-Br-M (murine) ecotropic retroviral transforming sequence
BD Biosciences
mouse monoclonal (17/c-Cbl) |
| In order to develop a new multiplex dSTORM imaging strategy to localize epitopes on activated T-cells, BD Biosciences CBL antibody (BD Biosciences, 610442) was used in immunocytochemistry on human samples (fig s12). Mol Biol Cell (2016) ncbi |
mouse monoclonal (17/c-Cbl) |
| In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences CBL antibody (BD, 17) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi |
mouse monoclonal (17/c-Cbl) |
| BD Biosciences CBL antibody (BD Bioscience, 610442) was used in immunocytochemistry on human samples (fig s10). Nat Commun (2015) ncbi |
mouse monoclonal (17/c-Cbl) |
| BD Biosciences CBL antibody (BD transduction, 610441) was used in western blot on human samples (fig 5). J Cell Sci (2015) ncbi |
mouse monoclonal (17/c-Cbl) |
| BD Biosciences CBL antibody (BD Biosciences, 610441) was used in western blot on human samples (fig 4). Carcinogenesis (2014) ncbi |
Articles Reviewed
- Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments